Accéder au contenu
Merck

Scopolamine infusion in the basolateral amygdala after saccharin intake induces conditioned taste avoidance in rats.

Psychopharmacology (2024-06-01)
Víctor Manuel Torres-García, Emmanuel Rodríguez-Nava, Rosa Itzel Alcántara-Rivas, Ofir Picazo, Gabriel Roldán-Roldán, Jean-Pascal Morin
RÉSUMÉ

Muscarinic receptor activity in the basolateral amygdala (BLA) is known to be involved in plasticity mechanisms that underlie emotional learning. The BLA is involved in the Attenuation of Neophobia, an incidental taste learning task in which a novel taste becomes familiar and recognized as safe. Here we assessed the role of muscarinic receptor activity in the BLA in incidental taste learning. Young adult male Wistar rats were bilaterally implanted with cannulas aimed at BLA. After recovery, rats were randomly assigned to either vehicle or muscarinic antagonist group, for each experiment. We tested the effect of specific and non-specific muscarinic antagonists administered either 1) 20 min before novel taste presentation; 2) immediately after novel taste presentation; 3) immediately after retrieval (the second taste presentation on Day 5 -S2-) or immediately after the fifth taste presentation on Day 8 (S5). Non-specific muscarinic receptor antagonist scopolamine infused prior to novel taste, while not affecting novel taste preference, abolished AN, i.e., the increased preference observed in control animals on the second presentation. When administered after taste consumption, intra-BLA scopolamine not only prevented AN but caused a steep decrease in the taste preference on the second presentation. This scopolamine-induced taste avoidance was not dependent on taste novelty, nor did it generalize to another novel taste. Targeting putative postsynaptic muscarinic receptors with specific M1 or M3 antagonists appeared to produce a partial taste avoidance, while M2 antagonism had no effect. These data suggest that if a salient gustatory experience is followed by muscarinic receptors antagonism in the BLA, it will be strongly and persistently avoided in the future. The study also shows that scopolamine is not just an amnesic drug, and its cognitive effects may be highly dependent on the task and the structure involved.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
(−)-Scopolamine hydrobromide trihydrate, ≥98% (HPLC), powder